Cargando…

Breast cancer recurrence: factors impacting occurrence and survival

BACKGROUND: Breast cancer mortality has decreased due to improved screening and treatment options. Nevertheless, 25–30% of patients develop disease recurrence and die from the disease dissemination. Patients who develop metastatic disease represent a heterogeneous group and management plans are depe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Courtney, Donald, Davey, Matthew G., Moloney, Brian M., Barry, Michael K., Sweeney, Karl, McLaughlin, Ray P., Malone, Carmel M., Lowery, Aoife J., Kerin, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671998/ https://www.ncbi.nlm.nih.gov/pubmed/35076871 http://dx.doi.org/10.1007/s11845-022-02926-x

Ejemplares similares

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©
por: Davey, Matthew G., et al.
Publicado: (2022)

Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
por: McGuire, Andrew, et al.
Publicado: (2017)

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021)

Evolution of breast cancer management in Ireland: a decade of change
por: Heneghan, Helen M, et al.
Publicado: (2009)

Effects of Age on the Detection and Management of Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2015)

Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety
por: O’Halloran, Niamh, et al.
Publicado: (2017)

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
por: McAnena, Peter F., et al.
Publicado: (2018)

A radiomic model to classify response to neoadjuvant chemotherapy in breast cancer
por: McAnena, Peter, et al.
Publicado: (2022)

Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
por: McAnena, Peter F., et al.
Publicado: (2018)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
por: Davey, M G, et al.
Publicado: (2021)

The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer
por: Lowery, Aoife J, et al.
Publicado: (2008)

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021)

Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials
por: Davey, Matthew G, et al.
Publicado: (2023)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022)

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials
por: Davey, Matthew G., et al.
Publicado: (2022)

Evaluating the Clinical Utility of Routine Sentinel Lymph Node Biopsy and the Value of Adjuvant Chemotherapy in Elderly Patients Diagnosed With Oestrogen Receptor Positive, Clinically Node Negative Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2021)

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023)

The Wavelia Microwave Breast Imaging system–tumour discriminating features and their clinical usefulness
por: Moloney, Brian M, et al.
Publicado: (2021)

Comparing surgical outcomes of approaches to adrenalectomy — a systematic review and network meta-analysis of randomised clinical trials
por: Davey, Matthew G., et al.
Publicado: (2023)

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
por: Davoren, Pamela A, et al.
Publicado: (2008)

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G, et al.
Publicado: (2022)

Oncological Risk in Autologous Stem Cell Donation for Novel Tissue-Engineering Approaches to Postmastectomy Breast Regeneration
por: O’Halloran, Niamh, et al.
Publicado: (2019)

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

Trends in breast reconstruction practices in a specialized breast tertiary referral centre
por: O'Halloran, N., et al.
Publicado: (2017)

General data protection regulations (2018) and clinical research: perspectives of patients and doctors in an Irish university teaching hospital
por: Davey, Matthew G., et al.
Publicado: (2021)

Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer—A State-of-the-Art Review
por: Cronin, Michael, et al.
Publicado: (2023)

Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hed9etheaabgc72ukbjj26i5jq